article thumbnail

Deliberate Dysentery

Codon

A few people died in those early challenge trials, though, including a nurse named Clara Maass , who was challenged multiple times. There have been deaths in phase 1 medical and drug research among healthy participants. But there have been no deaths in human challenge studies in at least four decades. That's not coincidental.

Vaccine 132
article thumbnail

New Data Show Treatment with Lilly’s Neutralizing Antibodies Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV016) Together Reduced Risk of COVID-19 Hospitalizations and Death by 70 Percent

The Pharma Data

Lilly has received feedback from front-line nurses and doctors administering these infusions regarding the complexity and time requirements for preparation and administration. However, as with any such undertaking, there are substantial risks and uncertainties in the process of drug research, development and commercialization.